Establishing cost-effectiveness of genetic targeting of cancer therapies

Retèl, Valesca P. and Rutgers, E.J.Th. and Joore, M.A. and Harten van, W.H. (2011) Establishing cost-effectiveness of genetic targeting of cancer therapies. European Journal of Oncology Pharmacy, 5 (1). pp. 28-31. ISSN 1783-3914

Preview

PDF
248Kb

Abstract:	The clinical benefit of a new genomic instrument, the 70-gene signature for breast cancer patients, is being evaluated in a randomised clinical trial. The early, controlled implementation process is supported by a Constructive Technology Assessment to help decision-making in an uncertain time of development.
Item Type:	Article
Faculty:	Management and Governance (SMG)
Research Group:	Health Technology & Services Research (HTSR)
Link to this item:	http://purl.utwente.nl/publications/78769
Official URL:	http://www.ppme.eu/Publications/EJOP/Journal-information/Previous-issues/EJOP-Vol.5-2011-Issue-1/Feature/Establishing-cost-effectiveness-of-genetic-targeting-of-cancer-therapies
Export this item as:	BibTeX EndNote HTML Citation Reference Manager

Repository Staff Only: item control page